Recent
- Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
- Math Over Myth: Weekly Psychedelic Stocks News Roundup
- The Real Reason Cybin Bought Entheon’s DMT Clinical Trial
- This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!
- Psychedelic Business Spotlight – June 17
- Psychedelic Business Spotlight – June 10
- 5 Next-Generation Psychedelics Entering Clinical Trials This Year
- Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors
- Elon Musk Excites Psychedelic Industry CEOs with This Tweet
- My Favorite Psychedelic Stocks: Part 1
Cybin
Public Company
[stockdio-historical-chart symbol="CLXPF" stockExchange="" palette="financial-light"]